ArticleNucleic acids research2026
scParadise: tunable, highly accurate multi-level cell type annotation, unknown cell type identification, and modality imputation.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In single-cell biology, the main limitation has shifted from data generation to converting sparse, heterogeneous single-cell RNA sequencing (scRNA-seq) datasets into accurate cell types, interpretable multi-omic states, and reproducible conclusions. To address these challenges, we present scParadise, which transforms scRNA-seq data to a new scientific knowledge. scParadise comprises three integrated tools: scAdam, a multi-level cell type annotation tool with unknown cell type identification; scEve, a cross-tissue modality imputation tool; and scNoah, a standardized benchmarking tool. Using scParadise, we corrected annotation mistakes in the Tabula Muris Senis atlas, showing that cells labeled as granulocytes are exclusively neutrophils and that presumably annotated macrophages actually represent a range of different cell types. Moreover, we identify three previously unknown natural killer T (NKT) cell subsets by imputing protein expression across tissues, which include CD56dim CD3+, CD56dim CD3+ CD4+, and CD56dim CD3+ CD8+ cell subsets in human visceral adipose tissue, which we verify by flow cytometry. These new subsets engage in obesity-related tumor necrosis factor-centric crosstalk with myeloid and adipose progenitors, thereby illuminating a new paradigm for immune-stromal interactions that contribute to chronic inflammation and impaired adipogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.